Dr. Whitman, an experienced rheumatologist, has an active clinical practice treating patients with a variety of musculoskeletal and autoimmune diseases. With a focus on the importance of proper diagnosis and treatment, Dr. Whitman writes detailed patient care notes about his patients to help workup and treat each of their medical problems. Patients typically receive copies of his notes soon after their visit.
"As a rheumatologist, I work to determine early on whether a patient’s musculoskeletal complaint is degenerative, inflammatory, or infectious. I then want to determine the best treatment plan. My goal is to always establish a partnership with each patient, to work up a treatment plan, and to ‘think outside the box' to get the best acceptable solution.”
Dr. Whitman brings more than 30 years of experience and an extensive knowledge base to HSS. He completed his internship in Internal Medicine at Billings Hospital at the University of Chicago in 1976 and then his residency in Internal Medicine at the New York Hospital Cornell Medical Center in 1978 where he participated in a bench research training elective in the laboratory of Dr. Henry Kunkel with Dr. Robert Lahita. Dr. Whitman was also involved in a clinical research elective in Dr. John Laragh’s Hypertension and Cardiovascular Center studying hypertensive and cardiopulmonary complications of rheumatic disease, primarily with Dr. David Case.
A Rheumatology Fellow at Hospital for Special Surgery from 1978-1980, Dr. Whitman also maintained his connections with Rockefeller University and the Cardiovascular/Hypertension Division at NewYork-Presbyterian Hospital (NYPH). After his Rheumatology training, Dr. Whitman joined the Summit Medical Group in Summit, N.J. in Internal Medicine and Rheumatology, while continuing to work weekly for the Hypertension Center of the NYPH for thirty years.
Dr. Whitman’s paper on Scleroderma Renal Crisis was cited as one of the significant achievements in rheumatology in the past 75 years at the 75th Anniversary of the American College of Rheumatology in 2009 (See Publications for more information).
Attending Physician, Hospital for Special Surgery
Assistant Professor of Medicine, Weill Cornell Medical College
Osteoarthritis, Rheumatoid Arthritis, Scleroderma, Lupus, Mixed Connective Tissue Disease, Fibromyalgia, CFS
Blue Cross HMO POS
Blue Cross PPO
United Healthcare Compass
Please do not hesitate to contact our office if you have questions regarding your insurance coverage. You may still have coverage subject to the availability of 'out-of-network' benefits.
One of the goals of Hospital for Special Surgery (HSS) is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies if payments were received during the prior year, or if the HSS physician currently receives payment. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
As of May 25, 2015, Dr. Whitman reported no financial interest relationships with healthcare industry.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, HSS’ Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
Internal Medicine, 1978
New York, New Jersey
Whitman HH. Rheumato/oqic laboratory tests. JF Beary, CL Christian, TYP Sculco (eds). Manual of Rheumato/oqy and Outpatient Orthopedic Disorders. Boston: Uttle, Brown and Company, 1981, p. 13
Whitman HH. Scleroderma and Undifferentiated Connective Tissue Syndromes. IBID, p. 261
Whitman HH III, Case DB, LeRoy EC. Management of Hypertensive scleroderma patients with converting enzyme inhibition. In: Black C.M. and Meyers, A.R. (eds). Current topics in Rheumatology-Sytemic Sclerosis (Scleroderma) Gower Medical Publishing Ltd., New York, 1985.
Whitmann HH III, Clauw DJ, Beary JF III. Low Back Pain. In: Paget, S.A., Beary J.F. III, Gibofsky, A., Sculco, T.P. Low Back Pain. In Manual of Rheumatology and Outpatient Orthopedic Disorders Lippincott 5th Ed, Philadelphia, 2006.
Whitman, HH, Resnick, LM, Laragh, JH. Hypertensive response to TRH testing in scleroderma. Arthritis and Rheum. S4:24, 1982.
Whitman HH. At al. Variable Response to oral converting enzyme inhibitor in hypertensive scleroderma patients.
Arthritis Rheum. 25; 241-248, 1982
Case DB, Whitman HH, Spiera H. Successful low dose re-challenge with captopril (letter). Lancet 1: 1362-1363 1981
Niarchos AP, Whitman HH, Goldstein JE, Laragh JH. Hemodynamic effects of captopril in pulmonary hypertension of collagen vascular disease. Am Heart J. 104:834-8, 1982
Whitman HH, Case DB. New Developments in the treatment of scleroderma. Drug Therapy 97-104, December 1981
Fisher J, Borer JS, Moses JVV, Goldberg HL, Niarchos, Whitman HH, Mermelstein M. Hemodynamic effect of nifedipine versus hydralazine in primary pulmonary hypertension. Amer. J. Cardio/. 54:646-650, 1984
Fisher J, Borer JS, Moses JVV, Goldberg HL, Mack RH, Niarchos AP, Whitman HH, Mermelstein M. Comparative effects of nifedipine and hydralazine in pulmonary arterial hypertension. Cardiovasc. Rev. & Reports 7 (3):251258, 1986
Morse JH, Barst RJ, Whitman HH, Fotino M, Jacobs JC, Isolated pulmonary hypertension in the granchild of a kindred with Scleroderma: "Neonatal Scleroderma?" J. Rheumatol1989 Dee: 16 (12) 1536-41
Whitman HH 3rd, Fishman EK, Oberg K, Wildman JM, Long AL, Catecholamine secreting metastatic carcinoid as differential diagnosis in pheochromocytoma: clinical, laboratory, and imaging clues in the search for the lurking neuroendocrine tumor (NET). Ann NY Acad Sci 2006 Aug; 1073:59-78